Brendan Luu - Net Worth and Insider Trading

Brendan Luu Net Worth

The estimated net worth of Brendan Luu is at least $454,424 dollars as of 2024-04-29. Brendan Luu is the Sr. VP, Business Dev. of Enanta Pharmaceuticals Inc and owns about 36,736 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $454,424. Details can be seen in Brendan Luu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brendan Luu has not made any transactions after 2023-12-05 and currently still holds the listed stock(s).

Transaction Summary of Brendan Luu

To

Brendan Luu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brendan Luu owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .

Click here to see the complete history of Brendan Luu’s form 4 insider trades.

Insider Ownership Summary of Brendan Luu

Ticker Comapny Transaction Date Type of Owner
ENTA Enanta Pharmaceuticals Inc 2023-12-05 Sr. VP & Business Dev.

Brendan Luu Latest Holdings Summary

Brendan Luu currently owns a total of 1 stock. Brendan Luu owns 36,736 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $454,424.

Latest Holdings of Brendan Luu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTA Enanta Pharmaceuticals Inc 2023-12-05 36,736 12.37 454,424

Holding Weightings of Brendan Luu


Brendan Luu Form 4 Trading Tracker

According to the SEC Form 4 filings, Brendan Luu has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 2,125 shares on December 5, 2023, which brought Brendan Luu around $20,464.

Insider Trading History of Brendan Luu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brendan Luu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brendan Luu Ownership Network

Ownership Network List of Brendan Luu

No Data

Ownership Network Relation of Brendan Luu


Brendan Luu Owned Company Details

What does Enanta Pharmaceuticals Inc do?

Who are the key executives at Enanta Pharmaceuticals Inc?

Brendan Luu is the Sr. VP & Business Dev. of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Chief Scientific Officer Yat Sun Or .

Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary

Over the past 18 months, Brendan Luu made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 2,125. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .

In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.

Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enanta Pharmaceuticals Inc Insider Transactions

No Available Data

Brendan Luu Mailing Address

Above is the net worth, insider trading, and ownership report for Brendan Luu. You might contact Brendan Luu via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.

Discussions on Brendan Luu

No discussions yet.